Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
FLOW: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results
Author(s): Richard Pratley Added: 8 months ago
EASD 24 - We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.Interview Questions:1. What is the reasoning behind the FLOW Trial?2. What was the patient population and study design?3. What are the key results?4. Were there any surprising or unexpected findings?5. What further… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Hypertensive Disorders of Pregnancy
Author(s): Ariana Traub , Apoorva Sharma , Maria Carolina Gongora Added: 1 year ago

Prevention & Chronic Conditions
Cardio-obstetrics in the CICU: An Introductory Guide
Author(s): Jenna Skowronski , Eleanor Christenson , Kayle Shapero , et al Added: 1 month ago

CV Disease in Special Populations

Heart Failure
Assessing Pregnancy Risk in Patients with Congenital Heart Disease
Author(s): Ajitha Kulasekaran , Lorna Swan Added: 2 years ago

Demographic

Inherited and Congenital Cardiac Conditions
Prognostic Value of HF Stratification and Cardiologist Follow-Up
Author(s): Guillaume Baudry Added: 4 days ago
ESC HF 25 - Findings from a French nationwide cohort study investigating cardiologist follow-up show greater reduction in all-cause mortality associated with annual cardiology hospital visits.Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) discusses findings from a nationwide trial investigating the prognostic value of heart failure stratification and cardiologist follow-up in… View more

Heart Failure
ESC HF 25: The PRAISE-HFrEF Study
Author(s): Varun Sundaram Added: 6 days ago
ESC HF 25 - Safety outcomes from PRAISE-HFrEF show that glucagon-like peptide-1 receptor agonism (GLP-1 RA) treatment for heart failure with reduced ejection fraction (HFrEF) and obesity was not associated with increased risk of heart failure hospitalisation or mortality compared to placebo, with greater benefits observed in patients with higher BMI.Dr Varun Sundaram (Case Western Reserve… View more

Cardiovascular Renal Metabolic

Heart Failure
Research Area(s) / Expertise: Job title: Pediatric and Maternal HIV/AIDS
EuroPCR 25: The DANAMI-3-DEFER Trial
Author(s): Jacob Thomsen Lønborg Added: 3 days ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent… View more

Intervention

MI/ACS
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 7 hours ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
EuroPCR 25: The REVEAL-AFMR Registry
Author(s): Tomohiro Kaneko Added: 1 day ago
EuroPCR 25 - Real-world findings from the REVEAL-AFMR registry show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR).We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from the REVEAL-AFMR… View more

Intervention